David Feinberg, M.D.

Edit your Faculty Profile
Work Titles
UCLA Director, Child and Adolescent Outpatient Evaluation and Treatment Clinic Associate Professor, Psychiatry and Biobehavioral Sciences Health Sciences Clinical Professor, Jane and Terry Semel Institute for Neuroscience and Human Behavior
Education:
Degrees:
M.D., Chicago Medical School, 1989
Fellowship:
1992 - 1994 UCLA School of Medicine
Internship:
1989 - 1990 Loyola University Medical Center
Residency:
1990 - 1992 UCLA School of Medicine
Certifications:
Certifications:
1996 American Board of Psychiatry and Neurology
1995 American Board of Psychiatry and Neurology

Contact Information:

Work Email Address:

dfeinberg@mednet.ucla.edu


Website:

Web-Profile

Work Phone Number:

(310) 267-3516

(310) 267-9315

Mailing Address:

757 Westwood Plaza, Suite 1320
Ronald Reagan UCLA Medical Center
Mail Code 740030
Los Angeles, CA 90095


Detailed Biography:

David Feinberg, MD, MBA is the chief executive officer of the UCLA Hospital System and associate vice chancellor. Prior to assuming the leadership role of CEO for UCLA Hospitals, Dr. Feinberg was the medical director of the Resnick Neuropsychiatric Hospital (NPH) at UCLA. He has been a faculty member in the Department of Psychiatry at the David Geffen School of Medicine since 1994. He is triple board certified in Child and Adolescent Psychiatry, Adult Psychiatry, and Addiction Psychiatry. Dr. Feinberg also has his master of business administration from Pepperdine University. Dr. Feinberg areas of expertise include Attention Deficit/Hyperactivity Disorder, Adolescent Substance Abuse and the business of medicine.

Publications:

A selected list of publications:

Feinberg David T   2007: a year of change? Journal of child and adolescent psychopharmacology, 2007; 17(2): 257.
Feinberg David T   Consumer-directed health care: not quite the cure yet Journal of child and adolescent psychopharmacology, 2007; 17(1): 143-4.
Feinberg David T   Are doctors elastic? Journal of child and adolescent psychopharmacology, 2006; 16(1-2): 5-6.
Feinberg David T   Insure kids now Journal of child and adolescent psychopharmacology, 2006; 16(3): 238.
Feinberg David T   The cost of over-the-counter substance abuse Journal of child and adolescent psychopharmacology, 2006; 16(6): 801-2.
Feinberg David T   Two giant steps forward Journal of child and adolescent psychopharmacology, 2006; 16(4): 503-4.
Feinberg David T   "Daddy, what is erectile dysfunction?" Direct-to-consumer advertising will be changing Journal of child and adolescent psychopharmacology, 2005; 15(6): 866-8.
Feinberg David T   Consumer driven health care Journal of child and adolescent psychopharmacology, 2005; 15(5): 717-9.
Feinberg David T   Crossing the health-care quality chasm: When will evidenced-based medicine take hold? Journal of child and adolescent psychopharmacology, 2005; 15(4): 529-31.
Feinberg David T   Dr. Robin Hood to cure California's mentally ill Journal of child and adolescent psychopharmacology, 2005; 15(2): 155-6.
Feinberg David T   Managed care. Crossroads Journal of child and adolescent psychopharmacology, 2005; 15(1): 3-4.
Feinberg David T   2002 annual reports: money and pharmaceuticals Journal of child and adolescent psychopharmacology, 2004; 14(1): 9-11.
Feinberg David T   Are "carve outs" in or out? Journal of child and adolescent psychopharmacology, 2004; 14(2): 161-3.
Feinberg David T   Medicare-approved prescription drug discount card program: will this really help our seniors? Journal of child and adolescent psychopharmacology, 2004; 14(3): 348-9.
Pataki Caroly S, Feinberg David T, McGough James J   New drugs for the treatment of attention-deficit/hyperactivity disorder Expert opinion on emerging drugs, 2004; 9(2): 293-302.
Feinberg David T, Miller Matt   Quality is in the eye of the beholder Journal of child and adolescent psychopharmacology, 2004; 14(4): 539-41.
Feinberg David T   Formularies and the like: what managed care companies are doing to keep pharmacy costs down Journal of child and adolescent psychopharmacology, 2003; 13(2): 119-21.
Feinberg David T   Opportunity from crisis: how medical cost offset helps our patients and may help save the system Journal of child and adolescent psychopharmacology, 2003; 13(3): 213-5.
Feinberg D T   Reimbursement, managed care, finances, and contracting issues Journal of child and adolescent psychopharmacology, 2003; 13(1): 7-8.
Feinberg David T   The real cost of pediatric bipolar disorder Journal of child and adolescent psychopharmacology, 2003; 13(4): 431-3.
Frankel F, Cantwell D P, Myatt R, Feinberg D T   Do stimulants improve self-esteem in children with ADHD and peer problems? Journal of child and adolescent psychopharmacology, 1999; 9(3): 185-94.
Frankel F, Myatt R, Cantwell D P, Feinberg D T   Parent-assisted transfer of children's social skills training: effects on children with and without attention-deficit hyperactivity disorder Journal of the American Academy of Child and Adolescent Psychiatry, 1997; 36(8): 1056-64.
Frankel F, Myatt R, Cantwell D P, Feinberg D T   Use of the Child Behavior Checklist and DSM-III-R diagnosis in predicting outcome of children's social skills training Journal of behavior therapy and experimental psychiatry, 1997; 28(2): 149-61.
Small G W, Feinberg D T, Steinberg D, Collins M T   A sudden outbreak of illness suggestive of mass hysteria in schoolchildren Archives of family medicine, 1994; 3(8): 711-6.
Feinberg D T, Hartman N   Methadone and schizophrenia The American journal of psychiatry, 1991; 148(12): 1750-1.

Does this profile need updating? Contact Us